By contrast, in HFD mice, as well as in human T2DM islets [4], it has been reported recently that reduced somatostatin signaling, combined with intrinsic changes in α-cells, including insensitivity to somatostatin, collectively leads to hyperglucagonemia [111]. The gene discussed is SST; the disease is type 2 diabetes mellitus.